It's likely that Direct has been slightly postponed due to the delay in MHRA approval of -L. LP was likely expecting approval last year, which would've helped provide funding to restart Direct in January. If it hasn't restarted yet, then Direct will restart soon after DCVax-L approval. IMO
Another decade would be reasonable. Multi-tasking is a foreign concept to them.
When the Direct program restarts they will shout from the roof top! They will need to raise a ton of capital for that and it’s best done after UK approval. Hopefully, that will also allow some longs to sell on the UK approval spike and not get caught in the subsequent wave of dilution and short attack.
Market Data 
Markets 
AI
